Patents Assigned to REMIX THERAPEUTICS INC.
  • COMPOUNDS AND METHODS FOR MODULATING SPLICING
    Publication number: 20230167093
    Abstract: The present disclosure features compounds and related compositions that, inter alia, modulate nucleic acid splicing, e.g., splicing of a pre-mRNA, as well as methods of use thereof.
    Type: Application
    Filed: April 8, 2021
    Publication date: June 1, 2023
    Applicants: REMIX THERAPEUTICS INC., REMIX THERAPEUTICS INC.
    Inventors: Dominic Reynolds, Serge Leger, Michael W. Seiler, Anant A. Agrawal, Frederic Vaillancourt, Peter Smith, Allen T. Hopper, Olivier Soueidan